MCCHRLS-B Fair Value & Analysis
IN · Market cap ₹9.2B
Fair value as of: Jul 8, 2026
From 8 valuation models · updated 13 days ago
Share price +0.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹551.30 – ₹740.80 · fair‑value band ₹97.94 – ₹376.89 · the ₹699.00 price screens above the ₹218.18 fair value. As of Jul 8, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
MCCHRLS-B (MCCHRLS-B) currently trades at ₹699.00, while our model-based Fair Value estimate is ₹218.18, implying the stock looks roughly 68.8% overvalued today. We read business quality at 38/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at ₹1.1B. Net debt stands at ₹15.0B. Fundamentals as of Jul 8, 2026
Our scenario range runs from ₹97.94 (bear case) to ₹376.89 (bull case); at ₹699.00, the current price sits above that range. The share trades about 11% below its 52-week high and 37% above its 52-week low, currently above its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 8, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
MCCHRLS-B reported revenue of ₹1.1B in FY2026 versus ₹106M in FY2022, a compound +79.8%/yr. Reported net income was −₹1.2B in FY2026.
Is MCCHRLS-B fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is MCCHRLS-B undervalued?
What is the fair value of MCCHRLS-B?
What is the quality score of MCCHRLS-B?
What is the revenue of MCCHRLS-B?
What is the net profit margin of MCCHRLS-B?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full MCCHRLS-B analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.